No price history available.
Key financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | ¥m | 22,954 | 27,803 | 32,224 | 29,326 | 30,802 | 38,423 | N/A | N/A |
| Operating profit | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | ¥m | 1,082 | 1,503 | 2,956 | 1,443 | 2,026 | 1,643 | N/A | N/A |
| EPS reported | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Hirakawa Hewtech Corp., headquartered in Tokyo, Japan, was established in 1948, operating initially as Hirakawa Electric Wire Corporation before adopting its current name in October 1990. The company engages in the global manufacturing and distribution of a diverse range of cables, electronic equipment, and medical devices. Its extensive product lineup includes highly specialized super-fine coaxial cables for precise medical instruments, board-in cables for mounting applications, and wire harnesses crucial for internal and inter-machine wiring in multimedia and industrial apparatus. They also provide digital interface cables for signal transmission, Infiniband cables facilitating connections between servers and storage, and durable factory automation cables designed for industrial machinery like robots and machine tools. Additionally, their offerings encompass LCD cables for connecting notebook computer displays to main boards, and various broadcasting cables, such as optical camera cables and HC-4E6 microphone cords. Beyond cabling, Hirakawa Hewtech supplies flexible and power cords, power supply components, EMI shielding products, and broadcast and network solutions. A key area of its business involves the development, production, and sale of specialized medical tubing and related processed goods, serving the medical, analysis equipment, and other niche industrial sectors. Furthermore, the company offers comprehensive design, execution, and management services for electrical and telecommunications projects, alongside its activities in real estate leasing and management.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Hirakawa Hewtech Corp. (5821.T)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Hirakawa Hewtech Corp., headquartered in Tokyo, Japan, was established in 1948, operating initially as Hirakawa Electric Wire Corporation before adopting its current name in October 1990. The company engages in the global manufacturing and distribution of a diverse range of cables, electronic equipment, and medical devices. Its extensive product lineup includes highly specialized super-fine coaxial cables for precise medical instruments, board-in cables for mounting applications, and wire harnesses crucial for internal and inter-machine wiring in multimedia and industrial apparatus. They also provide digital interface cables for signal transmission, Infiniband cables facilitating connections between servers and storage, and durable factory automation cables designed for industrial machinery like robots and machine tools. Additionally, their offerings encompass LCD cables for connecting notebook computer displays to main boards, and various broadcasting cables, such as optical camera cables and HC-4E6 microphone cords. Beyond cabling, Hirakawa Hewtech supplies flexible and power cords, power supply components, EMI shielding products, and broadcast and network solutions. A key area of its business involves the development, production, and sale of specialized medical tubing and related processed goods, serving the medical, analysis equipment, and other niche industrial sectors. Furthermore, the company offers comprehensive design, execution, and management services for electrical and telecommunications projects, alongside its activities in real estate leasing and management.
